Arkolith/Insider Trading/KYTX/Form 4

Westlake BioPartners Opportunity Fund I, L.P.

10% OwnerKyverna Therapeutics, Inc. (KYTX) · full profile →Form 4 · filed Dec 22, 2025
Net Buying
Open-Market Buys
$1000K
Open-Market Sells
$0
Net Open-Market Flow
$1000K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 18, 2025Buy(P)133K$7.50$1000K869K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-25-123596) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML